Latest Articles

  • Should anticoagulation be resumed after intracerebral hemorrhage?
    Joshua N. Goldstein, MD, PhD and Steven M. Greenberg, MD, PhD
    Cleveland Clinic Journal of Medicine November 2010, 77 (11) 791-799; DOI: https://doi.org/10.3949/ccjm.77a.10018

    In selected patients, the potential benefit of resuming anticoagulation outweighs the considerable risk.

  • How soon after hip fracture surgery should a patient start bisphosphonates?
    Margaret Seton, MD
    Cleveland Clinic Journal of Medicine November 2010, 77 (11) 751-755; DOI: https://doi.org/10.3949/ccjm.77a.10045

    Starting a bisphosphonate too soon after surgery could disrupt bone remodeling and delay fracture repair.

  • In reply: How to prevent glucocorticoid-induced osteoporosis (August 2010)
    Robin K. Dore, MD
    Cleveland Clinic Journal of Medicine November 2010, 77 (11) 762; DOI: https://doi.org/10.3949/ccjm.77c.10003
  • Influenza 2010–2011: Lessons from the 2009 pandemic
    Michael G. Ison, MD, MS and Nelson Lee, MD
    Cleveland Clinic Journal of Medicine November 2010, 77 (11) 812-820; DOI: https://doi.org/10.3949/ccjm.77a.10135

    The 2009 pandemic of influenza A (H1N1) was less severe than some others, thanks in part to advances in diagnosis, treatment, and public health.

  • Intracerebral hemorrhage: Pick your poison
    Franklin Michota, MD, FHM
    Cleveland Clinic Journal of Medicine November 2010, 77 (11) 743-746; DOI: https://doi.org/10.3949/ccjm.77a.10103

    Whether to resume anticoagulant therapy after an intracerebral hemorrhage requires careful consideration of many factors, including patient preferences and tolerance of different levels of risk.

  • When ‘blue babies’ grow up: What you need to know about tetralogy of Fallot
    David Fox, ME, PA-C, Ganesh P. Devendra, BA, Stephen A. Hart, BS and Richard A. Krasuski, MD
    Cleveland Clinic Journal of Medicine November 2010, 77 (11) 821-828; DOI: https://doi.org/10.3949/ccjm.77a.09172

    Children born with tetralogy of Fallot and other congenital heart defects are living longer—long enough, eventually, to present to your clinic.

  • What’s new in treating older adults?
    Barbara Messinger-Rapport, MD, PhD, CMD
    Cleveland Clinic Journal of Medicine November 2010, 77 (11) 770-790; DOI: https://doi.org/10.3949/ccjm.77gr.10002

    Recent studies and trials regarding bone loss, dialysis outcomes, dementia, and other topics.

  • Management of hyponatremia: Providing treatment and avoiding harm
    Management of hyponatremia: Providing treatment and avoiding harm
    Chirag Vaidya, MD, Warren Ho, MD and Benjamin J. Freda, DO
    Cleveland Clinic Journal of Medicine October 2010, 77 (10) 715-726; DOI: https://doi.org/10.3949/ccjm.77a.08051

    Undercorrection of acute symptomatic hyponatremia can lead to serious neurologic injury, but so can overly rapid correction of chronic hyponatremia.

  • Is there a doctor in your house? Home health care of the future
    John Hickner, MD, MSc
    Cleveland Clinic Journal of Medicine October 2010, 77 (10) 681-682; DOI: https://doi.org/10.3949/ccjm.77a.10100

    A modernized, efficient, effective home health care system would be a welcome improvement on the patchwork system we have had for the past 30 years.

  • Finding the right target for treating Alzheimer disease
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine October 2010, 77 (10) 650; DOI: https://doi.org/10.3949/ccjm.77b.10010

    It is not always easy to pick a therapeutic target. Sometimes, potential targets are actually embers of the pathologic process rather than flames driving the disease.

Pages